Exposure of PHGDH-kd ER+ breast cancer cells to cytotoxic chemotherapy (carboplatin or doxorubicin) leads to increased mitochondrial ROS and blocks the enrichment of CSCs induced by chemotherapy [166,167]. The gene discussed is ESR1; the disease is breast carcinoma.